Pneumonia as a systemic illness

Current Opinion in Pulmonary Medicine
Charles Feldman, Ronald Anderson

Abstract

The manuscript reviews the recent literature describing the occurrence, risk factors, recognition and treatment of sepsis, respiratory failure, and multiple organ dysfunction in patients with community-acquired pneumonia (CAP). CAP may present with varying degrees of disease severity ranging from an almost asymptomatic infection to a fulminant systemic disease with both respiratory failure and multiple organ dysfunction. Severe sepsis occurs early in the course of the infection in more than 30% of cases. It may involve several organ systems and is associated with the severity and mortality of CAP. A number of factors exist, which may promote the transition of CAP from a local to a systemic disease, particularly immunosuppression and poorly controlled inflammatory responses, which promote extrapulmonary dissemination of the causative pathogens. Although CAP may be associated with complications involving most organ systems, much recent research has focused attention on cardiac complications, particularly those associated with pneumococcal infections. Biomarkers as a strategy for discriminating between invasive and noninvasive CAP have been comprehensively studied. A number of treatment strategies using antibiotics and various adj...Continue Reading

References

Mar 9, 2000·The New England Journal of Medicine·J P NuortiR F Breiman
Apr 2, 2005·Clinics in Chest Medicine·Michelle A Beutz, Edward Abraham
May 14, 2005·Critical Care Medicine·Pierre-Francois LaterreUNKNOWN PROWESS Clinical Evaluation Committee
Sep 5, 2008·The European Respiratory Journal·M I RestrepoA Anzueto
Dec 22, 2012·The European Respiratory Journal·Marthe S PaatsMenno M van der Eerden
Feb 22, 2014·Inflammation·Rafael Fernandez-BotranJose Bordon
Aug 1, 2014·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S P van MensB J M Vlaminckx
Jan 24, 2015·The European Respiratory Journal·Antoni TorresMichael Niederman
Feb 26, 2015·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·M R BacciF L A Fonseca
Jun 20, 2015·The American Journal of Cardiology·Roberto CangemiUNKNOWN SIXTUS Study Group
Sep 2, 2015·The American Journal of Emergency Medicine·Birdal YıldırımSelmin Dirgen Çaylak
Dec 4, 2015·The Cochrane Database of Systematic Reviews·Djillali AnnaneYizhak Kupfer
Jan 5, 2016·PloS One·Beatriz MontullUNKNOWN NAC Calidad Group
Aug 3, 2016·Journal of Critical Care·Mari C de la TorreJordi Almirall
Aug 11, 2016·The Journal of Infection·Rosario MenéndezAntoni Torres
Aug 29, 2016·Critical Care : the Official Journal of the Critical Care Forum·Jason PhuaTow Keang Lim
Sep 7, 2016·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·F S BitekerH Sözen
Sep 21, 2016·Intensive Care Medicine·Martin KolditzUNKNOWN CAPNETZ Study Group
Nov 18, 2016·PloS One·Luis F ReyesCarlos J Orihuela
Dec 14, 2016·Seminars in Respiratory and Critical Care Medicine·Marcos I RestrepoAntonio Anzueto
Dec 15, 2016·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·K Z VardakasM E Falagas
Dec 17, 2016·Clinica Chimica Acta; International Journal of Clinical Chemistry·Pin-Yu ChangShun-Fa Yang
Jan 25, 2017·Current Opinion in Anaesthesiology·Josef BriegelPatrick Möhnle
Feb 6, 2017·Current Infectious Disease Reports·André Almeida, Matteo Boattini
Feb 17, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Francesco VioliUNKNOWN SIXTUS (Thrombosis-Related Extrapulmonary Outcomes in Pneumonia) Study Group
Mar 30, 2017·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A J M LoonenA J C van den Brule
Jun 15, 2017·American Journal of Respiratory and Critical Care Medicine·Otavio T RanzaniAntoni Torres
Jun 15, 2017·American Journal of Respiratory and Critical Care Medicine·Luis F ReyesCarlos J Orihuela
Jul 18, 2017·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Byunghyun KimSung Phil Chung
Aug 15, 2017·The American Journal of Medicine·Thomas J MarrieDean T Eurich

❮ Previous
Next ❯

Citations

Sep 22, 2018·Current Opinion in Critical Care·Catia CillónizAntoni Torres
Jan 15, 2019·Current Opinion in Infectious Diseases·Marin H Kollef, Kevin D Betthauser
Sep 12, 2019·Breathe·Diego Severiche-BuenoGrant W Waterer
Jan 30, 2020·Medical Sciences : Open Access Journal·Catia CillónizAntoni Torres
Oct 29, 2019·Expert Opinion on Emerging Drugs·Adamantia LiapikouToni Torres
May 23, 2021·Advanced Drug Delivery Reviews·Anna Lena JungBirke J Benedikter
Jul 3, 2021·Biomédica : revista del Instituto Nacional de Salud·Zonia Katerin AlarcónJaime Moreno
Sep 29, 2021·The Korean Journal of Internal Medicine·Yoon Suk JungChang Mo Moon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.